Laboratory of Neuropsychology, The University of Hong Kong, Hong Kong, SAR, China.
Psychother Psychosom. 2017;86(4):241-253. doi: 10.1159/000470847. Epub 2017 Jun 24.
Mindfulness-based cognitive therapy (MBCT) is a potential treatment for chronic insomnia. We evaluated the efficacy of MBCT for insomnia (MBCT-I) by comparing it with a sleep psycho-education with exercise control (PEEC) group.
Adults with chronic primary insomnia (n = 216) were randomly allocated to the MBCT-I or PEEC group. The MBCT-I included mindfulness and psycho-education with cognitive and behavioural components under cognitive behavioural therapy for insomnia. PEEC included psycho-education of sleep hygiene and stimulus control, and exercises. Any change in insomnia severity was measured by the Insomnia Severity Index (ISI). Secondary outcomes included sleep parameters measured by a sleep diary, health service utilisation, absence from work and mindfulness measured by the Five Facet Mindfulness Questionnaire.
The ISI score significantly decreased in the MBCT-I group compared with the PEEC group at 2 months (i.e., post-intervention) (p = 0.023, effect size [95% CI] -0.360 [-0.675, -0.046]) but not at 5 or 8 months. Treatment response rates and remission rates based on the ISI cut-off scores were not significantly different between groups. Wake time after sleep onset (WASO) was less in the MBCT-I group at 2 and 5 months. At 8 months, both groups showed a reduced ISI score, sleep onset latency and WASO, and increased sleep efficiency and total sleep time; however, no group differences were seen. Other outcome measures did not significantly improve in either group.
Long-term benefits were not seen in MBCT-I when compared with PEEC, although short-term benefits were seen.
基于正念的认知疗法(MBCT)是治疗慢性失眠的一种潜在方法。我们通过将 MBCT 用于失眠(MBCT-I)与睡眠心理教育结合运动控制(PEEC)组进行比较,评估了 MBCT-I 治疗失眠的疗效。
将 216 名慢性原发性失眠成年人随机分配到 MBCT-I 或 PEEC 组。MBCT-I 包括正念和认知行为治疗失眠的心理教育以及认知和行为成分。PEEC 包括睡眠卫生和刺激控制的心理教育以及运动。使用失眠严重程度指数(ISI)衡量失眠严重程度的任何变化。次要结果包括睡眠日记测量的睡眠参数、卫生服务利用、缺勤和使用五因素正念问卷测量的正念。
与 PEEC 组相比,MBCT-I 组在 2 个月(即干预后)时 ISI 评分显著降低(p = 0.023,效应大小[95%CI]-0.360[-0.675,-0.046]),但在 5 或 8 个月时则没有。基于 ISI 截断分数的治疗反应率和缓解率在两组之间没有显著差异。MBCT-I 组在 2 个月和 5 个月时的入睡后醒来时间(WASO)较少。在 8 个月时,两组的 ISI 评分、入睡潜伏期和 WASO 均降低,睡眠效率和总睡眠时间增加;但是,两组之间没有差异。其他结果指标在两组中均未显著改善。
与 PEEC 相比,MBCT-I 没有长期获益,尽管短期获益明显。